GENETIC-DETERMINANTS OF PLASMA FACTOR-VII ACTIVITY IN THE JAPANESE

被引:0
作者
KARIO, K
NARITA, N
MATSUO, T
KAYABA, K
TSUTSUMI, A
MATSUO, M
MIYATA, T
SHIMADA, K
机构
[1] HYOGO PREFECTURAL AWAJI HOSP,HYOGO,JAPAN
[2] KOBE UNIV,SCH MED,INT CTR MED RES,KOBE,JAPAN
[3] AKAIKE HOSP,DEPT INTERNAL MED,FUKUOKA,JAPAN
[4] NATL CARDIOVASC CTR,RES INST,OSAKA,JAPAN
[5] JICHI MED SCH,DEPT COMMUNITY & FAMILY MED,MINAMI KAWACHI,TOCHIGI,JAPAN
[6] JICHI MED SCH,DEPT CARDIOL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the frequency of the factor VII Gln353 (FVII Gln353) allele in Japan, where coronary artery disease is much less common and factor VII coagulant activity (FVIIc) is lower than in Western countries. Japanese males (n = 144) aged 40-59 years living in 2 different districts were studied, and the FVIIc and activated factor VII (FVIIa) levels were measured with human (FVIIa Hum) and bovine soluble tissue factor (FVIIa Bov). The frequency of the FVII Gln353 allele in the 2 districts was 0.026 and 0.052 (combined: 0.034), which was about one third of that in a European population. Thus, the lower FVIIc level in Japanese is not due to the effect of FVII Gln353 allele. Ten individuals with the Gln353 allele showed a 39% decrease of FVIIa Hum levels and a 29% decrease of the FVIIa Bov level compared with 134 individuals homozygous for the FVII Arg353 allele. These decreases of FVIIa were greater than the decrease of FVIIc (17%), suggesting that FVII Gln353 may be difficult td activate in vivo. The marked decrease of FVIIa levels in individuals with the FVII Gln353 allele suggests that they are genetically protected against cardiovascular disease irrespective of ethnic background, by virtue of their decreased FVIIa level.
引用
收藏
页码:617 / 622
页数:6
相关论文
共 50 条
  • [41] THE FUNCTION OF FACTOR-VII
    ACKROYD, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1956, 2 (04) : 397 - 411
  • [42] TISSUE FACTOR PATHWAY INHIBITOR ACTIVITY IN FACTOR-VII DEFICIENCY
    CELLA, G
    VIANELLO, A
    BOERI, G
    TOFFOLI, S
    PAOLINI, R
    RAMPIN, E
    GIROLAMI, A
    JOURNAL OF MEDICINE, 1995, 26 (3-4) : 189 - 191
  • [43] FACTOR-VII ASSAYS
    HAYES, TE
    PIKE, J
    TRACY, RP
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1993, 117 (01) : 52 - 57
  • [44] ISOLATION AND CHARACTERIZATION OF HUMAN FACTOR-VII - ACTIVATION OF FACTOR-VII BY FACTOR-X
    BAJAJ, SP
    RAPAPORT, SI
    BROWN, SF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1981, 256 (01) : 253 - 259
  • [45] HUMAN FACTOR-VII
    BROZE, GJ
    MAJERUS, PW
    METHODS IN ENZYMOLOGY, 1981, 80 : 228 - 237
  • [46] PREGNANCY AND FACTOR-VII
    HUBBARD, AR
    PARR, LJ
    BAINES, MG
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 80 (02) : 265 - 266
  • [47] FACTOR-VII DEFICIENCY
    RAGNI, MV
    LEWIS, JH
    SPERO, JA
    HASIBA, U
    AMERICAN JOURNAL OF HEMATOLOGY, 1981, 10 (01) : 79 - 88
  • [48] FACTOR-VII INHIBITOR
    CAMPBELL, E
    SANAL, S
    MATTSON, J
    WALKER, L
    ESTRY, S
    MUELLER, L
    SCHWARZ, M
    HAMPTON, S
    AMERICAN JOURNAL OF MEDICINE, 1980, 68 (06) : 962 - 964
  • [49] GASTRECTOMY IN CONGENITAL FACTOR-VII DEFICIENCY UNDER SUBSTITUTION WITH FACTOR-VII CONCENTRATE
    SCHRICKER, KT
    NEIDHARDT, B
    MEDIZINISCHE KLINIK, 1981, 76 (19) : 534 - 536
  • [50] HEREDITARY FACTOR-VII DEFICIENCY IN PREGNANCY - PERIPARTUM TREATMENT WITH FACTOR-VII CONCENTRATE
    ROBERTSON, LE
    WASSERSTRUM, N
    BANEZ, E
    VASQUEZ, M
    SEARS, DA
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 40 (01) : 38 - 41